Donor/Recipient Insurance Coverage: Protecting Against Unexpected Liability



Oocyte donation (OD) was originally intended for reproductive-aged women with premature ovarian failure and women with intractable infertility. However, currently OD serves the reproductive needs of a more diverse group of women, including women of advanced maternal age and postmenopausal patients. Despite oocyte donation being an expensive procedure, its popularity can be attributed to its high rate of success. Oocyte donation is now more commonly performed than ever. Yet, inherent risks to both the donor and recipient still exist. Measures to protect all parties, including the IVF practices that offer such services, from potential expenses secondary to complications must be established to maintain a viable and operationally sound program.


Insurance Policy Medical Expense Premature Ovarian Failure Oocyte Donation Ovarian Hyperstimulation Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Sauer MV, Kavic SM. Oocyte and embryo donation 2006: reviewing two decades of innovation and controversy. Reprod Biomed Online. 2006;12:153–62.PubMedCrossRefGoogle Scholar
  2. 2.
    Buster JE, Bustillo M, Thorneycroft IH, Simon JA, Boyers SP, Marshall JR, et al. Non-surgical transfer of in vivo fertilised donated ova to five infertile women: report of two pregnancies. Lancet. 1983;2:223–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Trounson A, Leeton J, Besanko M, Wood C, Conti A. Pregnancy established in an infertile patient after transfer of a donated embryo fertilised in vitro. Br Med J (Clin Res Ed). 1983;286:835–8.CrossRefGoogle Scholar
  4. 4.
    Klein J, Sauer MV. Oocyte donation. Best Pract Res Clin Obstet Gynaecol. 2002;16:277–91.PubMedCrossRefGoogle Scholar
  5. 5.
    Thinking of Becoming an Egg Donor. New York State Task Force on Life and the Law – Advisory Group on Assisted Reproductive Technologies.
  6. 6.
    Sauer MV, Paulson RJ, Lobo RA. Rare occurrence of ovarian hyperstimulation syndrome in oocyte donors. Int J Gynaecol Obstet. 1996;52:259–62.PubMedCrossRefGoogle Scholar
  7. 7.
    Sauer MV. Defining the incidence of serious complications experienced by oocyte donors: a review of 1000 cases. Am J Obstet Gynecol. 2001;184:277–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Bukulmez O, Li Q, Carr BR, Leader B, Doody KM, Doody KJ. Repetitive oocyte donation does not decrease serum anti-Mullerian hormone levels. Fertil Steril. 2010;94:905–12.PubMedCrossRefGoogle Scholar
  9. 9.
    Gelbaya TA. Short and long-term risks to women who conceive through in vitro fertilization. Hum Fertil (Camb). 2010;13:19–27.CrossRefGoogle Scholar
  10. 10.
    Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril. 2004;82:405–14.PubMedCrossRefGoogle Scholar
  11. 11.
    Konishi I, Kuroda H, Mandai M. Review: gonadotropins and development of ovarian cancer. Oncology. 1999;57 Suppl 2:45–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. 2008 guidelines for gamete and embryo donation: a Practice Committee report. Fertil Steril. 2008;90:S30–44.Google Scholar
  13. 13.
    Jain T, Harlow BL, Hornstein MD. Insurance coverage and outcomes of in vitro fertilization. N Engl J Med. 2002;347:661–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Egg Donor/Recipient Insurance. 2011. ART Risk Insurance and Financial Solution, Inc.
  15. 15.
    Fertility Insurance Program. 2012. Brown & Brown, Inc.
  16. 16.
    Reproductive Technology Risk Solutions. 2012. Beitler Services, Inc.
  17. 17.
    IVF Insurance Payment Program Plan. 2003-2012. © New Life Agency, Insurance Agency, Inc.
  18. 18.
    Accident and Health Insurance. 2012. © 2012 American International Group, Inc. http://www.­

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, College of Physicians and SurgeonsColumbia University, New York Presbyterian Hospital-Columbia University Medical CenterNew YorkUSA

Personalised recommendations